PARKVILLE, Australia--(BUSINESS WIRE)--CSL Limited today celebrated its 40th year as a leading manufacturer of the influenza (flu) vaccine. The company’s vaccine, Fluvax®, is a Thiomersal-free influenza vaccine that is approved for use in adults and children in Australia and New Zealand. This vaccine is known as Afluria™, Enzira™, Nilgrip™, and X-Flu™ in 17 different countries, including the US and European markets. Additionally, CSL supplies the antigen used to manufacture the flu vaccine in 24 countries.
